Bioadaptives Inc (BDPT)

$0.03 0.00 (-9.69%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 3,900
Avg Vol 49,838
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 30%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and c...

Industry: Packaged Foods
Sector: Consumer Defensive
Phone: 702 659 8829
Address:
2620 Regatta Drive, Suite 102, Las Vegas, United States
RobertVanhuss215
RobertVanhuss215 Aug. 1 at 4:17 PM
AITX continues to scale its robotics deployment while $BDPT is still in the development stage. That 4× revenue multiple looks undervalued for what AITX is building.
2 · Reply
70mustang
70mustang Jul. 29 at 4:42 PM
$BDPT does anyone know when the dividend stock that was ussued back in January will be tradable?
4 · Reply
70mustang
70mustang Jul. 22 at 6:19 PM
$BDPT what happened here today
2 · Reply
RayIngersoll776
RayIngersoll776 Jul. 22 at 4:45 PM
AITX delivers on growth—institutional funding, Fortune 500 interest, robotics traction. $BDPT remains highly speculative with no operational updates.
0 · Reply
MarianChavis603
MarianChavis603 Jul. 17 at 4:49 PM
$BDPT traders hope for biotech sparks, but AITX is a grounded AI-tech firm scaling with healthcare providers today.
1 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 17 at 3:01 PM
$BDPT L2 looking thin here watching LT
0 · Reply
Newdie999
Newdie999 Jul. 17 at 1:50 PM
$BDPT testing the floor of the hourly LRC. OBV is at the lowest it has been in at least 2 weeks. Maybe we see the floor develop here.
1 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 16 at 5:42 PM
InvestorNewsBreaks – $BDPT Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025 https://ibn.fm/KHwuX
0 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 16 at 3:29 PM
$BDPT green on news L2 looks thin watching.065
0 · Reply
SHEEPWOLF
SHEEPWOLF Jul. 16 at 2:18 PM
$BDPT NeuroRush™: BioAdaptives’ next-gen nootropic! • For professionals & seniors • Promotes mental endurance • Adaptogen-powered • Hits markets in 2025 https://youtu.be/YqVMplo2gVw
0 · Reply
Latest News on BDPT
No data available.
RobertVanhuss215
RobertVanhuss215 Aug. 1 at 4:17 PM
AITX continues to scale its robotics deployment while $BDPT is still in the development stage. That 4× revenue multiple looks undervalued for what AITX is building.
2 · Reply
70mustang
70mustang Jul. 29 at 4:42 PM
$BDPT does anyone know when the dividend stock that was ussued back in January will be tradable?
4 · Reply
70mustang
70mustang Jul. 22 at 6:19 PM
$BDPT what happened here today
2 · Reply
RayIngersoll776
RayIngersoll776 Jul. 22 at 4:45 PM
AITX delivers on growth—institutional funding, Fortune 500 interest, robotics traction. $BDPT remains highly speculative with no operational updates.
0 · Reply
MarianChavis603
MarianChavis603 Jul. 17 at 4:49 PM
$BDPT traders hope for biotech sparks, but AITX is a grounded AI-tech firm scaling with healthcare providers today.
1 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 17 at 3:01 PM
$BDPT L2 looking thin here watching LT
0 · Reply
Newdie999
Newdie999 Jul. 17 at 1:50 PM
$BDPT testing the floor of the hourly LRC. OBV is at the lowest it has been in at least 2 weeks. Maybe we see the floor develop here.
1 · Reply
NetworkNewsWire
NetworkNewsWire Jul. 16 at 5:42 PM
InvestorNewsBreaks – $BDPT Prepares for National Launch of NeuroRush(TM) Nootropic in Late Summer 2025 https://ibn.fm/KHwuX
0 · Reply
MONEYBAGSCLAY
MONEYBAGSCLAY Jul. 16 at 3:29 PM
$BDPT green on news L2 looks thin watching.065
0 · Reply
SHEEPWOLF
SHEEPWOLF Jul. 16 at 2:18 PM
$BDPT NeuroRush™: BioAdaptives’ next-gen nootropic! • For professionals & seniors • Promotes mental endurance • Adaptogen-powered • Hits markets in 2025 https://youtu.be/YqVMplo2gVw
0 · Reply
GeraldSmart873
GeraldSmart873 Jul. 16 at 2:05 PM
AITX gets a reorder from a top 25 healthcare provider. $BDPT is still chasing social media buzz with no confirmed contracts or recurring income.
0 · Reply
Newdie999
Newdie999 Jul. 16 at 1:55 PM
$BDPT’s NeuroRush taps a projected 18% CAGR nootropic market, now slated to hit $31B by 2029. This builds on their global wellness angle, pushing into cognitive performance. $BDPT takeaways: – Already in pets, weight‑management, stem‑cell division – This expands reach into human cognitive supplements – Aligns with past clinical trials (e.g. Zeranovia weight‑loss) – Smart‑to‑market strategy: diversify without diluting brand https://www.otcmarkets.com/stock/BDPT/news/BioAdaptives-Announces-National-Launch-of-NeuroRush--A-Cutting-Edge-Adaptogenic-Nootropic-for-Mental-Clarity-Focus-and-R?id=486043 #Wellness #MentalPerformance #GrowthStocks #BDPT
1 · Reply
Newdie999
Newdie999 Jul. 16 at 1:41 PM
$BDPT rolls out NeuroRush™, an adaptogenic nootropic for mental clarity, focus, and resilience—with no stimulants or crashes. Targeted at gamers, professionals, and seniors. $BDPT breakdown: – Based on TCM + Ayurvedic adaptogens – Market: $10B (2021) → $31B by 2029 – Designed to support mitochondrial energy—boosts endurance & focus – Stimulant-free formula avoids caffeine spikes https://www.otcmarkets.com/stock/BDPT/news/BioAdaptives-Announces-National-Launch-of-NeuroRush--A-Cutting-Edge-Adaptogenic-Nootropic-for-Mental-Clarity-Focus-and-R?id=486043 #Nootropic #CognitiveHealth #Adaptogens #BDPT
0 · Reply
Yunskit
Yunskit Jul. 11 at 4:50 PM
$BDPT chases biotech trials. AITX just completed a two-year test — and passed — to secure emergency services infrastructure.
0 · Reply
NetworkNewsWire
NetworkNewsWire Jun. 24 at 7:50 PM
InvestorNewsBreaks – $BDPT to Launch Pawpa(TM) Regen Nationwide as Stem Cell-Based Canine Supplement Gains Momentum https://ibn.fm/S7szn
0 · Reply
AmandaBlakes1061
AmandaBlakes1061 Jun. 19 at 2:57 PM
$BDPT is in biotech trials with little commercial proof. AITX already commercializes AI tech with real clients and a growing deployment pipeline.
0 · Reply
ShaunPetri911
ShaunPetri911 Jun. 2 at 5:15 PM
$BDPT AITX's 35 Fortune 500 prospects represent a potential gold mine — each one could lead to multi-unit, multi-year deployments worth millions in recurring revenue. The land-and-expand potential here is enormous, and the SOC 2 certification now removes the last barrier to these enterprise deals.
0 · Reply
NetworkNewsWire
NetworkNewsWire May. 28 at 7:25 PM
InvestorNewsBreaks – $BDPT Showcases Breakthrough Stem Cell Benefits in Regen Dog Chews https://ibn.fm/TZd16
0 · Reply
Abregap310
Abregap310 May. 16 at 12:10 PM
$BDPT fun day yesterday…let’s do it again!
0 · Reply
70mustang
70mustang May. 8 at 6:32 PM
$BDPT quickly losing my patience with this company. no movement in s.p., and no news, no financial statements.. almost time to move on for me
1 · Reply
70mustang
70mustang May. 1 at 2:40 PM
$BDPT snoooze fest...when are these guys going to announce anything else...so stagnant
0 · Reply
NetworkNewsWire
NetworkNewsWire Mar. 13 at 4:12 PM
InvestorNewsBreaks – $BDPT Completes Successful Dosage Trials for Zeranovia™ Weight Loss Product https://ibn.fm/GIZTp
0 · Reply